Tack Optimized Balloon Angioplasty Post-Market Study
Conditions: PAD - Peripheral Arterial Disease; PAD; Dissection; Arterial Dissection; Peripheral Arterial Disease; Peripheral Vascular Diseases Intervention: Device: The Tack Endovascular System Sponsor: Spectranetics Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Selution Sirolimus-eluting Balloon for Internal Pudendal-penile Artery Disease-related Erectile Dysfunction
Conditions: Erectile Dysfunction; Peripheral Arterial Disease; Arterial Stenosis Interventions: Device: Selution SLR™ sirolimus-eluting balloon; Device: Plain old balloon angioplasty Sponsors: National Taiwan University Hospital; M.A. Med Alliance S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Tack Optimized Balloon Angioplasty Post-Market Study
Conditions: PAD - Peripheral Arterial Disease; PAD; Dissection; Arterial Dissection; Peripheral Arterial Disease; Peripheral Vascular Diseases Intervention: Device: The Tack Endovascular System Sponsor: Spectranetics Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Selution Sirolimus-eluting Balloon for Internal Pudendal-penile Artery Disease-related Erectile Dysfunction
Conditions: Erectile Dysfunction; Peripheral Arterial Disease; Arterial Stenosis Interventions: Device: Selution SLR™ sirolimus-eluting balloon; Device: Plain old balloon angioplasty Sponsors: National Taiwan University Hospital; M.A. Med Alliance S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Tack Optimized Balloon Angioplasty Post-Market Study
Conditions: PAD - Peripheral Arterial Disease; PAD; Dissection; Arterial Dissection; Peripheral Arterial Disease; Peripheral Vascular Diseases Intervention: Device: The Tack Endovascular System Sponsor: Spectranetics Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Selution Sirolimus-eluting Balloon for Internal Pudendal-penile Artery Disease-related Erectile Dysfunction
Conditions: Erectile Dysfunction; Peripheral Arterial Disease; Arterial Stenosis Interventions: Device: Selution SLR™ sirolimus-eluting balloon; Device: Plain old balloon angioplasty Sponsors: National Taiwan University Hospital; M.A. Med Alliance S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Tack Optimized Balloon Angioplasty Post-Market Study
Conditions: PAD - Peripheral Arterial Disease; PAD; Dissection; Arterial Dissection; Peripheral Arterial Disease; Peripheral Vascular Diseases Intervention: Device: The Tack Endovascular System Sponsor: Spectranetics Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Selution Sirolimus-eluting Balloon for Internal Pudendal-penile Artery Disease-related Erectile Dysfunction
Conditions: Erectile Dysfunction; Peripheral Arterial Disease; Arterial Stenosis Interventions: Device: Selution SLR™ sirolimus-eluting balloon; Device: Plain old balloon angioplasty Sponsors: National Taiwan University Hospital; M.A. Med Alliance S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Tack Optimized Balloon Angioplasty Post-Market Study
Conditions: PAD - Peripheral Arterial Disease; PAD; Dissection; Arterial Dissection; Peripheral Arterial Disease; Peripheral Vascular Diseases Intervention: Device: The Tack Endovascular System Sponsor: Spectranetics Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Selution Sirolimus-eluting Balloon for Internal Pudendal-penile Artery Disease-related Erectile Dysfunction
Conditions: Erectile Dysfunction; Peripheral Arterial Disease; Arterial Stenosis Interventions: Device: Selution SLR™ sirolimus-eluting balloon; Device: Plain old balloon angioplasty Sponsors: National Taiwan University Hospital; M.A. Med Alliance S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Tack Optimized Balloon Angioplasty Post-Market Study
Conditions: PAD - Peripheral Arterial Disease; PAD; Dissection; Arterial Dissection; Peripheral Arterial Disease; Peripheral Vascular Diseases Intervention: Device: The Tack Endovascular System Sponsor: Spectranetics Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Selution Sirolimus-eluting Balloon for Internal Pudendal-penile Artery Disease-related Erectile Dysfunction
Conditions: Erectile Dysfunction; Peripheral Arterial Disease; Arterial Stenosis Interventions: Device: Selution SLR™ sirolimus-eluting balloon; Device: Plain old balloon angioplasty Sponsors: National Taiwan University Hospital; M.A. Med Alliance S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials
Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty: a structured protocol summary of the “SirPAD” randomized controlled trial
DiscussionBy focusing on clinically relevant outcomes, this study will provide useful information on the efficacy and safety of sirolimus-coated balloon catheters for infra-inguinal peripheral arterial disease in a representative ( “all-comer”) population of unselected patients. As regulatory agencies had raised safety concerns in patients exposed to paclitaxel-coated devices (versus uncoated ones), collect mortality data up to 5 years after randomization will be collected.Trial registrationClinicalTrials.govNCT04238546 (Source: Trials)
Source: Trials - April 21, 2022 Category: Research Source Type: clinical trials
A Real-world Registry Investigating Sirolimus-coated Balloon Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Dysfunctional Arteriovenous Fistula
Conditions: Dialysis Access Malfunction; Stenosis Interventions: Device: Sirolimus Drug Coated Balloon; Device: Paclitaxel Drug Coated Balloon Sponsor: Singapore General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2022 Category: Research Source Type: clinical trials
